Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis
Clinical trial NCT07530367 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07530367
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-08-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.